Land: Zwitserland
Taal: Italiaans
Bron: Swissmedic (Swiss Agency for Therapeutic Products)
virus varicellae vivus
MSD Merck Sharp & Dohme AG
J07BK02
virus varicellae vivus
Sospensione iniettabile
Vaccinum attenuatum: virus varicellae vivus min. 19400 U., saccharum, gelatina hydrolysata, ureum, natrii chloridum, natrii hydrogenoglutamas monohydricus, dinatrii phosphas, kalii dihydrogenophosphas, kalii chloridum, neomycinum, pro vitro. Solvens: aqua ad iniectabile.
B
Vaccini
Immunizzazione attiva contro l'Herpes Zoster e la Nevralgia post-erpetica, a partire dai 50. Compleanno
2007-02-22